Search Results - "Chang, Jason C."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma by Yang, Chen, Sanchez-Vega, Francisco, Chang, Jason C., Chatila, Walid K., Shoushtari, Alexander N., Ladanyi, Marc, Travis, William D., Busam, Klaus J., Rekhtman, Natasha

    Published in Modern pathology (01-11-2020)
    “…Primary pulmonary melanoma (PPM) is an entity recognized by the thoracic WHO classification. However, given the absence of native melanocytes in the lung and…”
    Get full text
    Journal Article
  5. 5

    Bronchiolar Adenoma/Pulmonary Ciliated Muconodular Papillary Tumor by Shirsat, Hemlata, Zhou, Fang, Chang, Jason C, Rekhtman, Natasha, Saqi, Anjali, Argyropoulos, Kimon, Azour, Lea, Simms, Anthony, Melamed, Jonathan, Hung, Yin P, Roden, Anja C, Mino-Kenudson, Mari, Moreira, Andre L, Narula, Navneet

    Published in American journal of clinical pathology (18-05-2021)
    “…Abstract Objectives To describe the histologic features that are helpful in the diagnosis of the rare bronchiolar adenomas/ciliated muconodular papillary…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Diagnosis of thoracic SMARCA4‐deficient undifferentiated tumor in cytology by Kezlarian, Brie, Montecalvo, Joseph, Bodd, Francis M., Chang, Jason C., Riedel, Elyn, White, Charlie, Rekhtman, Natasha, Sauter, Jennifer L.

    Published in Cancer cytopathology (01-08-2023)
    “…Introduction Although alterations in SMARCA4‐deficient occur in non–small cell lung carcinoma (SD‐NSCLC), thoracic SMARCA4‐deficient undifferentiated tumor…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Pathologic Assessment and Staging of Multiple Non–Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods by Chang, Jason C., Rekhtman, Natasha

    Published in Modern pathology (01-05-2024)
    “…Non–small cell lung carcinomas (NSCLCs) commonly present as 2 or more separate tumors. Biologically, this encompasses 2 distinct processes: separate primary…”
    Get full text
    Journal Article
  11. 11

    Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a clinicopathologic analysis by Chang, Jason C., M.D, Harrington, Alexandra M., M.D, Olteanu, Horatiu, M.D., Ph.D, VanTuinen, Peter, Ph.D, Kroft, Steven H., M.D

    Published in Annals of diagnostic pathology (01-12-2016)
    “…ABSTRACT OBJECTIVES Proliferation centers (PCs) are a characteristic finding in CLL/SLL lymph nodes, and their presence and extent in this site are not…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A cutaneous epithelioid vascular tumor harboring a TPM3::ALK fusion by Linos, Konstantinos, Chang, Jason C., Busam, Klaus J.

    Published in Genes chromosomes & cancer (01-01-2024)
    “…Substantial progress has been made in understanding the molecular pathways associated with vascular tumors over the last two decades. In addition to mutations…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Cellular Cutaneous Epithelioid Hemangioma Harboring the Rare GATA6::FOXO1 Gene Fusion by Tepp, Jonathan A, Agaram, Narasimhan P, Chang, Jason C, Linos, Konstantinos

    Published in The American journal of dermatopathology (01-04-2024)
    “…Epithelioid hemangioma (EH) is a benign vascular tumor displaying diverse histomorphologies. Among these, one EH subtype comprises cellular sheets of atypical…”
    Get full text
    Journal Article
  19. 19

    Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS by Rose Brannon, A., Jayakumaran, Gowtham, Diosdado, Monica, Patel, Juber, Razumova, Anna, Hu, Yu, Meng, Fanli, Haque, Mohammad, Sadowska, Justyna, Murphy, Brian J., Baldi, Tessara, Johnson, Ian, Ptashkin, Ryan, Hasan, Maysun, Srinivasan, Preethi, Rema, Anoop Balakrishnan, Rijo, Ivelise, Agarunov, Aaron, Won, Helen, Perera, Dilmi, Brown, David N., Samoila, Aliaksandra, Jing, Xiaohong, Gedvilaite, Erika, Yang, Julie L., Stephens, Dennis P., Dix, Jenna-Marie, DeGroat, Nicole, Nafa, Khedoudja, Syed, Aijazuddin, Li, Alan, Lebow, Emily S., Bowman, Anita S., Ferguson, Donna C., Liu, Ying, Mata, Douglas A., Sharma, Rohit, Yang, Soo-Ryum, Bale, Tejus, Benhamida, Jamal K., Chang, Jason C., Dogan, Snjezana, Hameed, Meera R., Hechtman, Jaclyn F., Moung, Christine, Ross, Dara S., Vakiani, Efsevia, Vanderbilt, Chad M., Yao, JinJuan, Razavi, Pedram, Smyth, Lillian M., Chandarlapaty, Sarat, Iyer, Gopa, Abida, Wassim, Harding, James J., Krantz, Benjamin, O’Reilly, Eileen, Yu, Helena A., Li, Bob T., Rudin, Charles M., Diaz, Luis, Solit, David B., Arcila, Maria E., Ladanyi, Marc, Loomis, Brian, Tsui, Dana, Berger, Michael F., Zehir, Ahmet, Benayed, Ryma

    Published in Nature communications (18-06-2021)
    “…Circulating cell-free DNA from blood plasma of cancer patients can be used to non-invasively interrogate somatic tumor alterations. Here we develop MSK-ACCESS…”
    Get full text
    Journal Article
  20. 20